R&D Navigating the new ICH E6 (R3): Key changes for sponsors These new regulations for running clinical trials in the UK will be a legal requirement from 28th April 2026.
R&D Sponsored Organoid neurotoxicity testing gains momentum Organoid-based approaches may become an integral part of neurological safety testing, offering a clearer view of risk.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
R&D Changing how the world finds new medicines: Physics modellin... Finding treatments for diseases afflicting humanity often proceeds at a crawl, leaving many serious medical needs unmet.
R&D The quiet evolution taking place in paediatric imaging In children, MRI is increasingly used for imaging of the central nervous system (CNS), chest, abdomen, pelvis and musculoskeletal tissue.
R&D DNA as a programmable language, with Adrian Woolfson and Kai... A new technology just announced this weekend in a paper in Nature could have a radical impact on how gene assembly is carried out.
Sales & Marketing On quality data for quality learnings, with Lisa Sims Nicole Raleigh speaks with Lisa Sims, executive director of learning strategy & operations at Novartis, about personalising learning at scale.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
